The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke
Published Guidelines (PDF)
Chapter 1
Introduction
Chapter 2
General Principles Concerning Laboratory Testing and Utility of Newer Biomarkers
Chapter 3
Inflammation Biomarkers and Cardiovascular Disease Risk
Chapter 4
Low-Density Lipoprotein Subclasses and Particle Size and Cardiovascular Disease Risk
Chapter 5
Lipoprotein (a) and Cardiovascular Disease Risk
Chapter 6
Apolipoproteins A-I and B and Cardiovascular Disease Risk
Chapter 7
Markers of Renal Impairment and Cardiovascular Disease Risk
Chapter 8
Homocysteine and Cardiovascular Disease Risk
Chapter 9
Natriuretic Peptides (BNP and NT-proBNP) and Cardiovascular Disease Risk
Chapter 10
Guideline Implementation